Previous 10 | Next 10 |
IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) will announce its first-quarter 2021 financial results before the market opens on Thursday, April 22, 2021. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time on that date. The earnings ...
Moleculin Engages IQVIA to Manage Potential COVID-19 Clinical Trial PR Newswire HOUSTON , April 6, 2021 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (Moleculin or the Company), a clinical stage pharmaceutical company with a broad portf...
Veeva is a dominant player in cloud-based life sciences applications, digitally transforming the entire industry with CRM and product lifecycle management. Performance metrics are superb with TTM revenue growth of 33%, free cash flow margin of 38%, and revenue retention rate of 124%. ...
Quest Diagnostics (DGX) announced the sale of its minority share in Q2 Solutions to IQVIA (IQV) for $760M in an all-cash transaction.Q2 Solutions, established as a JV (IQVIA and Quest) in 2015, is a global clinical laboratory services organization that provides comprehensive testing...
Quest Diagnostics Sells Ownership Interest in Q² Solutions to IQVIA PR Newswire SECAUCUS, N.J. and RESEARCH TRIANGLE PARK, N.C. , April 1, 2021 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services...
IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, today announced the acquisition of the 40 percent minority share of Q 2 Solutions from...
Glenview Capital Management’s 13F portfolio value increased from $3.19B to $4.36B this quarter. The number of positions increased from 45 to 54. They increased Lyft Inc. & Boston Scientific while reducing Meritor and Hologic during the quarter. The top three stakes are ...
Dan Loeb's 13F portfolio value increased from ~$10B to ~$13B this quarter. The number of positions increased from 47 to 73. Third Point added Alphabet and increased Avantor and Planet Fitness while reducing Amazon.com and Alibaba Group Holdings. The top three positions are at ~20%...
To date, IQVIA has enrolled more than 150,000 subjects across 10 therapy areas IQVIA ™ (NYSE:IQV) announced today that more than 60 trials spanning over 40 countries utilize its innovative decentralized clinical trial solutions as part of their respective registra...
IQVIA™ (NYSE: IQV) announces that since September 2020 it has been collaborating with Janssen Research & Development, LLC, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, on the Phase 3 COVID-19 vaccine clinical trials. The studies leverage IQVIA...
News, Short Squeeze, Breakout and More Instantly...
2024-07-23 10:00:13 ET Jailendra Singh from Truist Financial issued a price target of $300.00 for IQV on 2024-07-23 09:26:00. The adjusted price target was set to $300.00. At the time of the announcement, IQV was trading at $240.265. The overall price target consensus is...
2024-07-23 10:00:11 ET Elizabeth Anderson from Evercore ISI issued a price target of $270.00 for IQV on 2024-07-23 08:59:00. The adjusted price target was set to $270.00. At the time of the announcement, IQV was trading at $239.5. The overall price target consensus is at...
2024-07-23 07:00:06 ET Luke Sergott from Barclays issued a price target of $275.00 for IQV on 2024-07-23 05:25:00. The adjusted price target was set to $275.00. At the time of the announcement, IQV was trading at $245.23. The overall price target consensus is at $273.93 ...